Aprea Therapeutics
APRE
APRE
19 hedge funds and large institutions have $2.78M invested in Aprea Therapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
1
Closed
2
Calls
$416K
Puts
–
Net Calls
+$416K
Net Calls Change
-$199K
Top Buyers
Top Sellers
1 |
1
UBS Group
Zurich,
Switzerland
|
$9 |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$0 |
3 |
QC
3
Quent Capital
New York
|
$0 |